RAMIRO G PERU
CIK 1192045 · Executive VP and CFO · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.38M
Companies
7
Total Filings
85
Lifetime Open-Market Net
-$13.36M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELV | Director | 10,908 | $385.73 | $4.21M | -$410.7K | 7 | 2026-07-17 |
| SM | Director | 72,130 | $29.65 | $2.14M | -$2.13M | 23 | 2026-06-23 |
| Elevance Health, Inc. (ANTM) Delisted | Director | 10,395 | $482.58 | $5.02M | -$2.29M | 9 | 2022-05-20 |
| ANTX | Director | 13,571 | $4.70 | $63.8K | -$1.68M | 6 | 2017-06-01 |
| Elevance Health, Inc. (WLP) Delisted | Director | 24,402 | — | — | -$3.16M | 14 | 2013-06-03 |
| UNS Energy Corp (UNS) Delisted | Director | 4,000 | — | — | $106.4K | 18 | 2013-05-30 |
| PD | Executive VP and CFO | 93,910 | $10.31 | $968.2K | -$3.80M | 2 | 2007-03-01 |
Recent Filings · Page 4 of 9
85 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-23 | Elevance Health, Inc. (ANTM) Delisted | Sell (S) | −1,656 | -$455.4K | EDGAR |
| 2019-05-17 | Elevance Health, Inc. (ANTM) Delisted | Grant (A) | +753 | $0 | EDGAR |
| 2018-06-25 | SM | Grant (A) | +6,780 | $0 | EDGAR |
| 2018-05-21 | Elevance Health, Inc. (ANTM) Delisted | Sell (S) | −2,248 | -$520.6K | EDGAR |
| 2018-05-18 | Elevance Health, Inc. (ANTM) Delisted | Grant (A) | +753 | $0 | EDGAR |
| 2017-06-15 | SM | Grant (A) | +8,794 | $0 | EDGAR |
| 2017-06-01 | ANTX | Sell (S) | −2,681 | -$486.8K | EDGAR |
| 2017-05-22 | ANTX | Grant (A) | +990 | $0 | EDGAR |
| 2017-03-10 | SM | Buy (P) | +1,500 | $35.1K | EDGAR |
| 2017-02-28 | SM | Buy (P) | +1,000 | $25.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.